Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds

   
   

A thienopyrimidine compound of the formula: 1 wherein R.sub.1, R.sub.2, R.sub.3, and R.sub.4 are as defined herein, and methods of use of such compounds for the treatment of melanocortin receptor-associated disorders.

 
Web www.patentalert.com

< Novel compounds

< Network hospital is made as per all individuality diseases, on which one can choose corresponding commercial way for combined diet invigorating substances

> Computer-aided visualization and analysis system for signaling and metabolic pathways

> Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors

~ 00186